HOME >> BIOLOGY >> NEWS
Collaborative grant to Rutgers and Rep. of Georgia for salmonella research

Washington, D.C. -- U.S. Rep. Frank Pallone, Jr. (D-NJ) today announced a cooperative research anti-terrorism grant of $100,000 to a team of scientists from Rutgers, The State University of New Jersey, and the former Soviet Republic of Georgia to work on the development of a treatment against drug-resistant salmonella bacteria. The grant comes from the U.S. Civilian Research and Development Foundation (CRDF).

The joint U.S.-Georgian team is headed by Konstantin Severinov, associate professor at Rutgers' Waksman Institute of Microbiology and Tarasi Gabisonia of the Eliava Institute of Bacteriophage, Microbiology and Virology, Republic of Georgia. According to the CRDF, the team aims to create a novel treatment that could be used against all bacterial pathogens that cause salmonella infection in humans.

"This joint partnership between Rutgers and the Republic of Georgia can lead to a breakthrough treatment in the fight against salmonella infection," Pallone said. "These scientists will work to prevent massive outbreaks of salmonella poisoning, a threat that must be taken seriously in this post 9-11 world."

According to Dr. Severinov, "salmonella bacteria belong to a category of food or waterborne pathogens that are fairly easy to disseminate and can cause serious illness and in some cases lead to death. Since the early 1990s, strains of salmonella bacteria that are resistant to a variety of antibiotics have appeared and are threatening to become a serious health problem."

"As a result, interest in the use of a bacteriophage - virus that infects bacteria - treatment as alternative to antibiotic treatments has increased. Our Georgian colleagues have a unique expertise in phage therapy," Dr. Severinov said." "Together, we intend to develop a bacteriophage treatment that could be an effective remedy against massive outbreaks of drug-resistant salmonella."

The grant is part of a series of awards that fall under
'"/>

Contact: Andrew Souvall
Andrew.Souvall@mail.house.gov
202-225-4671
Rutgers, the State University of New Jersey
17-Jul-2003


Page: 1 2

Related biology news :

1. Collaborative research initiative aims to cut drug development time in half
2. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
3. NIMH awards $22.6 million for Center for Collaborative Research on Mental Disorders
4. DFG To Set Up 14 New Collaborative Research Centres
5. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
6. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
7. Florida Tech earns $50,000 grant to create coral database
8. $7.5 Million grant to Yale researchers for role of viruses in cancer
9. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
10. $2.7 million grant to support creation of virtual zebrafish atlas
11. Brown ecologist garners major National Science Foundation grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... management solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal ... most inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 ...
(Date:8/1/2018)... ... July 31, 2018 , ... ... Awards at Global Conference , Awards honor late founder of Wisdom National Brands® ... National Brands, presented prestigious stevia awards to a renowned German professor and a ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is now ... The treatments are offered by Double Board Certified providers, with outcomes significantly improving patient ... suppressing symptoms, but have done nothing to help repair and regenerate damaged lung tissues. ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/13/2017)... KING OF PRUSSIA, PA (PRWEB) , ... October 13, 2017 , ... ... Group Vice President and Turesol Business Unit Leader, will moderate a discussion on the ... this year’s ISPE Annual Meeting & Expo . The theme of this year’s ...
Breaking Biology Technology:
Cached News: